Peptide-powered wellness.
Direct-pay telehealth, 48 states + DC.
Frequently Asked Questions
GLP-1 weight loss, NAD+ therapy, sermorelin, pricing, and how clinician-prescribed peptides work — answered plainly.
TelePeptide GLP-1 programs start from $134/month (microdose GLP-1, 52-week prepay) and $169/month for full-dose compounded semaglutide (52-week prepay). Monthly billing without a prepay commitment runs $149-$249/month depending on the formulation. Programs are all-inclusive (clinician evaluation, prescription if clinically appropriate, medication shipped to the door from a licensed compounding pharmacy). No insurance required and no surprise fees. TelePeptide does not sell or distribute FDA-approved branded medications. Compounded preparations are not FDA-approved drugs, are not generic versions of branded medications, and are not represented as therapeutically equivalent to any FDA-approved product. Full price chart at telepeptide.org/pricing.
A licensed clinician may, where clinically appropriate, prescribe a compounded preparation of semaglutide or tirzepatide as part of an individualized treatment plan. TelePeptide currently provides telehealth services in 48 US states and the District of Columbia; we do not serve residents of Alaska or Mississippi at this time. Prescriptions are written by licensed US clinicians; compounded medications are dispensed by licensed 503A/503B compounding pharmacies. Compounded medications are not FDA-approved drugs and are not generic versions of branded products. No in-person visit is required.
The FDA has approved several GLP-1 receptor agonists for chronic weight management and type-2 diabetes. TelePeptide does not sell, distribute, or supply FDA-approved branded products. A licensed clinician may, where clinically appropriate, prescribe a compounded preparation of an active ingredient (such as semaglutide or tirzepatide) tailored to an individual patient. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded products, and are not represented as therapeutically equivalent. Whether a compounded preparation is appropriate is a clinical decision made by the prescribing clinician based on the individual patient.
FDA-approved branded GLP-1 medications go through full clinical trials and manufacturing review by the FDA. Compounded preparations are prepared by licensed 503A or 503B compounding pharmacies on a per-patient basis under specific federal rules. Compounded preparations are NOT FDA-approved drugs, are NOT generic versions of branded medications, and are not represented as therapeutically equivalent to any FDA-approved product. Whether a compounded preparation is clinically appropriate is an individualized decision made by the prescribing clinician based on full medical evaluation. TelePeptide does not sell, distribute, or represent branded medications.
TelePeptide provides a direct-pay (cash-pay) telehealth service for GLP-1 programs. You pay a flat monthly rate — from $134/month on the 52-week prepay plan, or $149–$249/month on monthly billing depending on the formulation. No insurance authorization, no prior authorizations, no pharmacy markup. HSA/FSA cards are not accepted yet — credit and debit cards are. The entire process is online: complete a medical intake form, a licensed clinician typically reviews your case within 48 hours, and your medication ships directly from a licensed pharmacy.
Most patients are prescribed and shipped within 3–5 business days. How it works: (1) complete the online intake — ~10 minutes; (2) a licensed clinician typically reviews your intake within 48 hours — by chart review or live audio/video consult, depending on your state's law; (3) prescription sent to a licensed pharmacy; (4) medication ships to your door, typically 2–3 business days.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that drives energy production (ATP synthesis), DNA repair, and cellular aging pathways. NAD+ levels are generally understood to decline with age. Supplementing NAD+ directly — via subcutaneous injection or IV infusion — bypasses the conversion step required by oral precursors like NMN or NR, producing faster and more reliable increases in cellular NAD+ levels. Research into NAD+ supplementation is ongoing, and much of it involves oral precursors rather than direct injection; potential effects such as energy and metabolic support are still being studied and are not established or FDA-evaluated. Compounded NAD+ is not an FDA-approved drug, and individual results are not guaranteed.
Yes. TelePeptide prescribes subcutaneous NAD+ injection protocols that patients self-administer at home — similar to how patients self-inject insulin or GLP-1 medications. A licensed clinician evaluates your history, prescribes the appropriate dose and protocol, and a licensed pharmacy ships the supplies to you. No IV clinic visit is needed.
NAD+ injection delivers the coenzyme directly to the bloodstream, bypassing the enzymatic conversion steps that NMN and NR require. Oral NMN and NR must be converted to NAD+ in the gut and liver — a process that varies significantly by individual and results in lower, less predictable bioavailability. Injectable NAD+ typically produces more consistent and faster increases in blood NAD+ levels. For people who have tried oral NMN/NR without clear results, injectable NAD+ is often more effective.
NAD+ injection therapy at TelePeptide is significantly less expensive than IV NAD+ at a clinic, which typically runs $250–$1,000 per session. TelePeptide's at-home NAD+ program starts at $129/month on the 52-week prepay plan ($169/month on monthly billing) and includes the clinician evaluation, prescription, and compounded NAD+ shipped to your home. Sermorelin starts at $99/month (annual). Full price chart at telepeptide.org/pricing.
Sermorelin is a growth hormone-releasing hormone (GHRH) analog — a 29-amino-acid peptide that stimulates the pituitary gland to produce and release growth hormone (GH) naturally. Unlike HGH injections, which introduce synthetic growth hormone directly, sermorelin works by signaling your own pituitary to increase GH output. This preserves the body's natural feedback loop, making sermorelin a more physiologically balanced approach. It has historically been used in clinical evaluation of adult growth-hormone deficiency and may be discussed with a licensed clinician in that context. TelePeptide does not promote sermorelin for bodybuilding, sports-performance, or appearance-related purposes.
Sermorelin and HGH serve different purposes. HGH injections introduce synthetic growth hormone directly, bypassing pituitary regulation — this can suppress natural GH production over time and carries more regulatory restrictions. Sermorelin stimulates your own pituitary to produce GH, preserving natural feedback. Because sermorelin acts through the body's own pituitary rather than introducing synthetic hormone, it preserves the natural GH feedback loop. Whether sermorelin is appropriate is an individualized clinical decision made by a licensed clinician, and it may be prescribed via telehealth where clinically appropriate. For patients with age-related GH decline rather than diagnosed GH deficiency, sermorelin is typically the preferred starting point.
A licensed clinician may, where clinically appropriate, prescribe sermorelin (a synthetic GHRH analog) as part of an individualized evaluation. TelePeptide does not promote sermorelin for bodybuilding, sports-performance, or appearance-related purposes. Service is available via telehealth in 48 US states and the District of Columbia (Alaska and Mississippi not currently served). No in-person visit is required for the consultation; sermorelin, when prescribed, is dispensed by a licensed compounding pharmacy and self-administered subcutaneously.
FDA-approved drugs in our therapeutic area include several branded semaglutide and tirzepatide products, insulin and insulin analogs, oxytocin, vasopressin, leuprolide, octreotide, and others. TelePeptide does not sell or distribute these branded products. Where clinically appropriate, a licensed clinician may prescribe a compounded preparation (for example, of an active ingredient like semaglutide, tirzepatide, or sermorelin) that is then dispensed by a licensed 503A or 503B compounding pharmacy. Compounded preparations are not FDA-approved drugs and are not generic versions of branded products.
Any prescription medication carries risks, contraindications, and potential side effects that must be evaluated individually by a licensed clinician. TelePeptide requires a medical history review and clinical consultation before any prescription is written. Patients should disclose all current medications, conditions, and history. If a prescription is issued, follow the clinician's instructions exactly and report any adverse effects promptly.
Yes. TelePeptide is a US-based direct-pay telehealth platform. Clinical services are provided by US-licensed clinicians through our contracted medical group (learn more at /providers). Where clinically appropriate, compounded medications are dispensed by licensed 503A/503B compounding pharmacies. TelePeptide operates under applicable federal and state telemedicine laws. The platform is based in the United States and currently serves patients in 48 US states and the District of Columbia (Alaska and Mississippi are not served at this time).
TelePeptide currently provides telehealth services in 48 US states and the District of Columbia. We do NOT serve residents of Alaska or Mississippi at this time. See our full state-coverage disclosure at telepeptide.org/state-coverage. The entire process — consultation, prescription, and medication delivery — is conducted remotely; no in-person clinic visit is required.
No. TelePeptide is a direct-pay (cash-pay) telehealth service. Insurance is not required and is not accepted. The flat monthly price covers everything: clinician evaluation, prescription, and medication. HSA/FSA cards are not accepted yet — credit and debit cards are.
Yes. Injectable peptides — including GLP-1 medications, NAD+, and sermorelin — require a valid prescription from a licensed clinician in the United States. Licensed clinicians in TelePeptide's contracted medical group evaluate your medical history and, when appropriate, issue prescriptions through the platform. You should never purchase injectable peptides without a prescription from a licensed US clinician and pharmacy — unregulated sources carry serious safety risks.
GLP-1 receptor agonists (such as semaglutide and tirzepatide) are FDA-approved for chronic weight management and type-2 diabetes; they reduce appetite and improve insulin sensitivity. NAD+ is an enzyme cofactor involved in cellular energy metabolism. Sermorelin is a synthetic GHRH analog historically used in clinical evaluation of adult growth-hormone deficiency. Each operates through a different mechanism. Whether any of these is clinically appropriate for an individual patient is determined by a licensed clinician during a telehealth evaluation.
A licensed clinician can review your specific situation and answer questions about which program is right for you — no commitment required.
TelePeptide Health is a US direct-pay telehealth platform that connects patients with licensed US clinicians for individualized medical evaluation. (The brand name is sometimes autocorrected to “telopeptide” — an unrelated collagen-fragment biomarker; the two terms have no clinical or commercial connection.) Where clinically appropriate, the prescribing clinician may issue a prescription that is then dispensed by a licensed 503A or 503B compounding pharmacy. Clinical services are provided by an independent, US-based medical group of licensed clinicians that TelePeptide contracts with; TelePeptide LLC is the technology platform and does not itself practice medicine.
Service area: 48 US states and the District of Columbia. We do not serve residents of Alaska or Mississippi at this time. See telepeptide.org/state-coverage.
What we do NOT claim: TelePeptide does not sell, distribute, or supply FDA-approved branded medications. Compounded preparations are not FDA-approved drugs, are not generic versions of branded drugs, and are not represented as therapeutically equivalent to any FDA-approved product. Lower price alone does not establish that a compounded preparation is equivalent to a commercially available drug. TelePeptide does not promote any therapy for bodybuilding, sports-performance, or appearance-related purposes, and does not promote substances that are not components of any FDA-approved drug. Treatment decisions are individualized clinical determinations made by the prescribing clinician.
Start an evaluation: telepeptide.org/intake · See pricing: telepeptide.org/pricing · State coverage: telepeptide.org/state-coverage